We are pleased to share Dr. Vince Clinical Research’s latest brochure, providing an in-depth overview of our full-service CRO solutions. Download the Brochure Contact Us Today to Learn More About our Clinical Trial Capabilities Name(Required) First Last...
The Cross-Company Abuse Liability Council (CCALC) meeting held in Washington, DC, covered several themes related to the evaluation of abuse potential, including behavioral economics, physical dependence, and adverse events (AEs); the discussion convened experts from...
As the leading CRO for Human Abuse Potential (HAP) studies, Dr. Vince Clinical Research has significant operational expertise in the conduct of these complex clinical trials where volunteer safety is paramount. Our clinical safety team is comprised of Advanced...
For centrally acting drugs, understanding abuse potential is crucial for public health and regulatory decision-making. The U.S. Food and Drug Administration (FDA) provides detailed guidelines on assessing abuse potential through its guidance, Assessment of Abuse...
Dr. Vince Clinical Research operates the ideal clinical site for Human Abuse Potential (HAP) studies. One feature of this facility is the on-site cGMP Pharmacy, built to comply with DEA standards, which is required to source the majority of reference or comparator...
Recent Comments